Profil
Leila Nicolas is currently working as an Investment Director at GO Capital SAS, as a Director at Acticor Biotech SAS, as a Director at VitaDx International SAS, and as a Director at PHAXIAM Therapeutics SA. Her former positions include being a Director at Graftys SA from 2019 to 2020, a Director at VitamFero SA from 2014 to 2018, a Director at Horama SA, a Product Manager at Bayer Pharma AG, and a Member-Supervisory Board at Pherecydes Pharma SA.
Postes actifs de Leila Nicolas
| Sociétés | Poste | Début |
|---|---|---|
| ACTICOR BIOTECH SAS | Director/Board Member | - |
| PHAXIAM THERAPEUTICS S.A. | Director/Board Member | 23/06/2023 |
GO Capital SAS
 GO Capital SAS Investment ManagersFinance GO Capital SAS (GO Capital) is an independent French private equity firm founded 2003 and is headquartered in Saint-Jacques-de-la-Lande. Formerly known as Grand Ouest Gestion SAS, the firm's investors include regional and cooperative banks, Natixis and CDC PME.GO Capital is located in Rennes and focuses primarily on the northwest quarter of France, also known as Grand Ouest, which comprises the Brittany, Poitou-Charentes, Pays de la Loire and Basse Normandie regions. The firm manages the Ouest Ventures fund. | Private Equity Investor | 01/01/2015 |
VitaDx International SAS
 VitaDx International SAS Medical SpecialtiesHealth Technology VitaDx International SAS develops a solution for early diagnosis of bladder cancer. It offers Fluorescence, a technology that can classify cancer cells as tumorous or healthy, and machine learning, a software analysis that used a set of mathematical techniques allowing algorithms to solve problems from data without being explicitly programmed. The company was founded by Allan Rodriguez in 2013 and is headquartered in Rennes, France. | Director/Board Member | 01/01/2017 |
Anciens postes connus de Leila Nicolas
| Sociétés | Poste | Fin |
|---|---|---|
Graftys SA
 Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France. | Director/Board Member | 01/01/2020 |
VitamFero SA
 VitamFero SA Pharmaceuticals: MajorHealth Technology VitamFero SA engages in the manufacture of pharmaceutical products and vaccines. It develops anti-infectious vaccines, first against Apicomplexe parasites such as toxoplasmosis agent, neosporosis agent and cryptosporidiosis agent. The firm is involved in the development of anti-parasite vaccines fulfilling unmet needs essentially in veterinary health. The company was founded on November 15, 2005 by Pascal Breton and Edouard Sèche and is headquartered in Evry, France. | Director/Board Member | 01/01/2018 |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Corporate Officer/Principal | - |
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Director/Board Member | - |
| PHERECYDES PHARMA | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ACTICOR BIOTECH SAS | Health Technology |
| PHAXIAM THERAPEUTICS S.A. | Health Technology |
| Entreprise privées | 7 |
|---|---|
GO Capital SAS
GO Capital SAS Investment ManagersFinance GO Capital SAS (GO Capital) is an independent French private equity firm founded 2003 and is headquartered in Saint-Jacques-de-la-Lande. Formerly known as Grand Ouest Gestion SAS, the firm's investors include regional and cooperative banks, Natixis and CDC PME.GO Capital is located in Rennes and focuses primarily on the northwest quarter of France, also known as Grand Ouest, which comprises the Brittany, Poitou-Charentes, Pays de la Loire and Basse Normandie regions. The firm manages the Ouest Ventures fund. | Finance |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Health Technology |
Graftys SA
Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France. | Health Technology |
VitamFero SA
VitamFero SA Pharmaceuticals: MajorHealth Technology VitamFero SA engages in the manufacture of pharmaceutical products and vaccines. It develops anti-infectious vaccines, first against Apicomplexe parasites such as toxoplasmosis agent, neosporosis agent and cryptosporidiosis agent. The firm is involved in the development of anti-parasite vaccines fulfilling unmet needs essentially in veterinary health. The company was founded on November 15, 2005 by Pascal Breton and Edouard Sèche and is headquartered in Evry, France. | Health Technology |
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Pherecydes Pharma SA is a biotechnology company, which engages in the research and development of anti-infective therapies based on the use of bacteriophages. It develops phage treatments of bacterial infections. The company was founded by Jerome Gabard and Manuel Gea in December 2006 and is headquartered in Romainville, France. | Health Technology |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | Health Technology |
VitaDx International SAS
VitaDx International SAS Medical SpecialtiesHealth Technology VitaDx International SAS develops a solution for early diagnosis of bladder cancer. It offers Fluorescence, a technology that can classify cancer cells as tumorous or healthy, and machine learning, a software analysis that used a set of mathematical techniques allowing algorithms to solve problems from data without being explicitly programmed. The company was founded by Allan Rodriguez in 2013 and is headquartered in Rennes, France. | Health Technology |
